EZH2 regulating miR-139 has been reported in various diseases; for instance, EZH2 exercises its pro-metastatic role by suppressing miR-139-5p expression in hepatocellular carcinoma [16]. This evidence concerns the gene EZH2 and hepatocellular carcinoma.